GT Biopharma Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy GT Biopharma Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for GT Biopharma Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for GT Biopharma Inc. is GTBP:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
GT Biopharma Inc. has its primary listing on NASDAQ (Small cap). You can trade GT Biopharma Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, GT Biopharma Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include GT Biopharma Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like GT Biopharma Inc..